Maravai LifeSciences Holdings, Inc.MRVINASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -2.49% | -23.92% | -27.00% | -35.43% | -36.15% |
| Gross Profit Growth | -5.98% | -51.42% | -70.11% | -77.89% | -80.07% |
| EBITDA Growth | -3648.47% | -103.03% | -1504.12% | -643.19% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +7.30% | +7.32% | +8.38% | +6.18% | +2.21% |
| Weighted Average Shares Diluted Growth | +7.30% | +5.74% | +8.38% | +6.18% | +2.21% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -7.27% | -287.91% | +0.00% | -158.88% | -215.33% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | -266.72% | -609.90% |
| Receivables Growth | -41.32% | -30.87% | -27.92% | -28.98% | -21.94% |
| Inventory Growth | +2.58% | -2.56% | -0.15% | -5.33% | -10.08% |
| Asset Growth | -43.63% | -32.22% | -33.56% | -38.04% | -33.56% |
| Book Value per Share Growth | -38.06% | -27.27% | -32.46% | -42.69% | -30.42% |
| Debt Growth | -8.72% | -38.34% | -34.13% | -35.29% | -93.61% |
| R&D Expense Growth | -0.07% | -0.72% | -2.86% | -7.61% | +124.91% |
| SG&A Expenses Growth | +0.57% | +7.19% | -3.23% | -4.88% | +99.91% |